NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality.

Author(s): Angel S, von Briesen H, Oh YJ, Baller MK, Zimmermann H, Germann A

Publication: Biopreserv Biobank, 2016, Vol. 14, Page 539-547

PubMed ID: 27792414 PubMed Review Paper? No

Purpose of Paper

This paper investigated the effects of temperature fluctuations during frozen storage on viability and recovery of peripheral blood mononuclear cells (PBMCs) and on T cell function.

Conclusion of Paper

Viability of cells decreased significantly after 200 temperature fluctuations and continued to decrease with additional cycles in specimens analyzed immediately after thawing and in those analyzed after overnight culture. Similarly, recovery decreased with increasing numbers of temperature fluctuations and decreases were significant after 150 temperature cycles in specimens analyzed immediately after thawing and beginning at 50 cycles for specimens cultured overnight. Linear regression analysis of T cell responses showed decreases with every 50th temperature cycle after peptide stimulation of cultured PBMCs.

Studies

  1. Study Purpose

    This study investigated the effects of temperature fluctuations during frozen storage on viability and recovery of PBMCs and on T cell functionality. PBMCs were isolated from buffy coat samples from four healthy cytomegalovirus (CMV)-seropositive donors (collection details not provided) by density gradient centrifugation (details not provided) and aliquots of 1 x 107 PBMCs/mL were frozen at a controlled rate of -1°C/min from +4°C to -80°C and then transferred into vapor-phase LN2 storage. To simulate specimen handling processes, aliquots were cycled 0-350 times from below -130°C to up to -60°C. This was accomplished using a robotic system that exposed the specimens to room temperature for ~5 minutes until the temperature inside the vial reached a defined temperature of -60°C and then returned them to vapor-phase LN2 storage. Three specimens were thawed in a water bath after every 50 cycles (0, 50, 100, 150, 200, 250, 300, 350), centrifuged at 400 x g for 6 min at room temperature, resuspended in medium and incubated overnight at 37°C and 5% CO2. Cell recovery and viability were determined using the trypan blue dye exclusion test and measured with an automated cell analyzer. To determine T cell response, 1 x 105 PBMCs cultured overnight were added to a 96-well plate pre-coated with anti-IFN-γ antibodies and then stimulated by addition of CMV pp65 peptides or CEF peptides (mixture of cytomegalovirus, Epstein-Barr virus, and influenza virus peptides) and incubation for 20–22 hours. Positive T cell response was determined by measurement of spot-forming cells (SFCs per million white cells) by an immunoassay analyzer.

    Summary of Findings:

    Viability of cells decreased significantly after 200 temperature fluctuations and continued to decrease with increasing cycles when compared to specimens not subjected to temperature fluctuations and analyzed immediately after thawing (P<0.05 all). Viability of cells after overnight culture decreased significantly after 200, 250, and 350 temperature cycles (P<0.05). Similarly, recovery of cells decreased with increasing numbers of temperature fluctuations with a significant difference observed after thaw after 150 temperature cycles (P<0.05) and after overnight culture beginning at 50 temperature fluctuations (P<0.05). Linear regression analysis of T cell responses showed decreases with every 50th temperature cycle of cultured cells after stimulation with CEF peptides (P=0.00529) or CMV peptides (P=0.01494) beginning after 50 cycles (-11.39% ± 9.52% after CEF stimulation and -7.38% ± 8.73% after CMV stimulation) and reaching a maximum decrease after 350 cycles (-27.70% ± 13.80% after CEF stimulation and -22.52% ± 11.44% after CMV stimulation).

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Cytomegalovirus
    Platform:
    AnalyteTechnology Platform
    Protein Immunoassay
    Cell count/volume Coulter counter
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Freeze/thaw cycling 0 cycles
    50 cycles
    100 cycles
    150 cycles
    200 cycles
    250 cycles
    300 cycles
    350 cycles

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...